πŸ‡ΊπŸ‡Έ FDA
Patent

US 11166964

Treatment for modulating gut microbiota

granted A61KA61K31/575A61K35/741

Quick answer

US patent 11166964 (Treatment for modulating gut microbiota) held by GALMED RESEARCH AND DEVELOPMENT LTD expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GALMED RESEARCH AND DEVELOPMENT LTD
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/575, A61K35/741, A61K35/747, A61K45/06